Zini Tanzi, Gina
 Distribuzione geografica
Continente #
EU - Europa 5.075
NA - Nord America 4.261
AS - Asia 2.790
SA - Sud America 651
AF - Africa 85
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.876
Nazione #
US - Stati Uniti d'America 4.140
DE - Germania 1.780
SG - Singapore 1.236
IT - Italia 1.206
CN - Cina 849
BR - Brasile 539
SE - Svezia 530
GB - Regno Unito 295
UA - Ucraina 291
FR - Francia 252
IE - Irlanda 159
ID - Indonesia 135
PL - Polonia 134
FI - Finlandia 131
IN - India 125
VN - Vietnam 110
RU - Federazione Russa 71
NL - Olanda 59
CA - Canada 58
TR - Turchia 52
AR - Argentina 44
BE - Belgio 40
HK - Hong Kong 39
MX - Messico 36
JP - Giappone 31
BD - Bangladesh 28
IQ - Iraq 27
ZA - Sudafrica 20
AT - Austria 19
ES - Italia 19
PK - Pakistan 19
EC - Ecuador 17
PE - Perù 16
IR - Iran 15
LT - Lituania 14
CI - Costa d'Avorio 13
CH - Svizzera 12
PT - Portogallo 12
SA - Arabia Saudita 12
KE - Kenya 11
MA - Marocco 11
CO - Colombia 10
IL - Israele 10
JO - Giordania 10
KR - Corea 10
PH - Filippine 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
CZ - Repubblica Ceca 9
RO - Romania 8
UZ - Uzbekistan 8
VE - Venezuela 8
EG - Egitto 7
DZ - Algeria 6
GE - Georgia 6
MY - Malesia 6
CL - Cile 5
DO - Repubblica Dominicana 5
EE - Estonia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
PY - Paraguay 5
BH - Bahrain 4
DK - Danimarca 4
ET - Etiopia 4
GR - Grecia 4
LB - Libano 4
NO - Norvegia 4
YE - Yemen 4
AM - Armenia 3
BZ - Belize 3
HN - Honduras 3
NG - Nigeria 3
PA - Panama 3
QA - Qatar 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
GH - Ghana 2
JM - Giamaica 2
LK - Sri Lanka 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
EU - Europa 1
Totale 12.855
Città #
Chandler 647
Singapore 513
Ashburn 380
Jacksonville 195
Beijing 186
San Mateo 174
Ann Arbor 169
Dublin 158
Dearborn 148
Nanjing 144
Milan 134
Los Angeles 118
Rome 117
Jakarta 112
Warsaw 112
Nürnberg 105
Munich 83
New York 82
Woodbridge 82
Cattolica 81
Dallas 80
Wilmington 78
Boston 71
Lawrence 66
Frankfurt am Main 63
Redmond 60
Fairfield 58
Seattle 58
Houston 57
Bremen 55
Nanchang 53
São Paulo 51
Redwood City 50
Hefei 49
Marseille 49
Lancaster 47
Moscow 39
Brussels 38
Hong Kong 35
Hangzhou 34
Hanoi 33
Helsinki 32
The Dalles 32
Naples 30
Izmir 29
Ho Chi Minh City 28
London 28
Norwalk 27
Leawood 25
Mountain View 25
Princeton 25
Shenyang 25
Boardman 24
Toronto 24
Zhengzhou 24
Chicago 23
Rio de Janeiro 23
Buffalo 22
Kunming 22
Shanghai 21
Tianjin 21
Brooklyn 20
Florence 20
Santa Clara 20
Turin 20
Turku 20
Guangzhou 19
Jiaxing 19
Palermo 19
Tokyo 19
Augusta 17
Columbus 17
Hebei 17
Düsseldorf 16
Cagliari 15
Pune 15
Cambridge 14
Falls Church 14
Hyderabad 14
San Francisco 14
University Park 14
Abidjan 13
Baghdad 13
Bologna 13
Genoa 13
Vienna 13
Bari 12
Brasília 12
Lima 12
Montreal 12
Johannesburg 11
Las Vegas 11
Mexico City 11
Orem 11
Paris 11
Poplar 11
Stockholm 11
Auburn Hills 10
Kent 10
Mumbai 10
Totale 5.937
Nome #
MORFOLOGIA DELLE MALATTIE DEL SANGUE Verduci Editore 987
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 349
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 328
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 306
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 280
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 274
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features 255
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 210
Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants 202
Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants 197
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 194
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 191
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 187
Weak D Type 4.2.2 (DAR1.2) in an African child: Serology and molecular characterization 187
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 175
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 166
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 163
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 162
Morphology of Blood Disorders 162
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 162
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 159
Hypoxia-inducible factor-1α(Pro-582-Ser) polymorphism prevents iron deprivation in healthy blood donors 158
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 157
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 157
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 153
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 150
Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors 150
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 145
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 144
Allogeneic umbilical cord blood red cell concentrates: An innovative blood product for transfusion therapy of preterm infants 141
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 140
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 140
TWO-GROUP STUDY OF MEDIAL MICROSCOPY AS A ROBUST TOOL TO HARMONIZE AND STANDARDIZE HAEMATOLOGICAL DIAGNOSIS 138
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 137
Transfusion of very low birth weight neonates using allogeneic cord blood derived RBC units. 137
Analysis of bone marrow aspiration fluid using automated blood cell counters. 137
Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria. 132
The role of molecular typing and perfect match transfusion in sickle cell disease and thalassaemia: An innovative transfusion strategy 131
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 129
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 127
Allogeneic cord blood red cells for transfusion 127
Increased levels of solubile intercellular adhesion molecole-1, neutrophils and elastase in the lung of preterm infants with bronchopulmonary displasia. 123
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 121
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 119
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 117
Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria 115
Primary myelofibrosis: when the clone manifests with Rh phenotype splitting 115
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 114
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 107
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 104
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 103
Fechtner syndrome: report of a third family and literature review 102
the concomitance of lymphoma and breast carcinoma in the bone 99
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes 98
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 97
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 97
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 97
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 96
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 96
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial 95
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 92
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 92
Medicine use in pregnancy and public cord blood bank databases 91
Fragmented red blood cells automated measurement is a useful parameter to exclude schistocytes on the blood film 89
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 88
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 87
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? 87
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 87
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 87
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 84
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 83
Leukemia diagnosis: today and tomorrow 82
Inline extracorporeal photopheresis: evaluation of cell collection efficiency 80
Diagnostics and prognostication of myelodysplastic syndromes 79
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions 79
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 78
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance 78
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 77
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 76
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas 74
CELL-BY-CELL ASSESSMENT OF MEDIAL MICROSCOPY (MM) AS A BETWEEN-OBSERVER TOOL FOR HARMONIZATION AND PROFICIENCY TESTING (ON BEHALF OF WP10 LEUKEMIANET DIAGNOSIS MORPHOLOGICAL FACULTY) 73
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets 72
The concomitance of lymphoma and breast carcinoma in the bone 71
Case of metastatic melanoma in bone marrow smear 67
Innovation in hematology: Morphology and flow cytometry at the crossroads 67
Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia 67
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 64
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 62
ICSH: on board for new projects 61
Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients 59
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 58
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 57
Schistocytes 57
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 57
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 57
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 56
INTRODUCTION 55
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 52
Research in morphology and flow cytometry is at the heart of hematology 51
Totale 12.974
Categoria #
all - tutte 48.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021450 0 0 0 0 0 39 70 32 114 29 157 9
2021/2022957 82 91 22 49 77 37 30 163 36 52 132 186
2022/20231.880 214 261 146 289 139 234 78 169 238 28 51 33
2023/2024970 55 253 33 64 48 142 86 26 23 37 105 98
2024/20252.075 45 72 150 100 222 98 98 99 281 208 402 300
2025/20262.420 721 136 268 409 702 184 0 0 0 0 0 0
Totale 12.974